QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rafarma Pharmaceuticals, Inc. (RAFA) Triggers Growth In Russian Economic Development Region, Subsequent Partnership Opportunity 0 comments
    Aug 2, 2013 1:23 PM

    The strategic selection of Terbuny, Russia, as the home for Rafarma Pharmaceuticals' world-class manufacturing facility has resulted in more biotech companies moving into the area, and has already provided Rafarma with specialized collaboration opportunities.

    A newly announced facility specifically devoted to dialysis research and product development will be located near Rafarma's pharmaceutical plant in Terbuny in the Lipetsk region of Russia, located just a few hours south from Moscow. Rafarma and the new dialysis facility intend to work together to develop dialysis-specific products.

    "Rafarma was one of the first to build and operate in Terbuny, and the company's success looks to be the start of a new biotech hub in Russia," Rafarma CEO Dave Anderson stated in the press release. "Rafarma is not only committed to growth as a company, but also to the development of Terbuny and its local economy and residents."

    Terbuny is part of a broader special economic development region that Russian pharmaceutical industry advocates anticipate will stimulate economic growth and jobs in the area. By constructing and maintaining its facilities in Terbuny, and staffing the plant with local residents, Rafarma is awarded specific government incentives which enhance the company's bottom line.

    From new 270,000 square-foot state-of-the-art manufacturing and distribution facility, Rafarma produces generic antibiotics and specialty pharmaceutical products in addition to its own line of proprietary products that have been approved by the Ministry of Health of Russian Federation.

    For the last three years, the Russian Government has taken considerable action to accelerate the development modernization of nation's domestic pharmaceutical industry. In line with this focus, Oleg Korolyov, governor of the Lipetsk region, praised the latest development in an article published at news.mail.ru: news.mail.ru/inregions/center/48/economi.../

    For more information, visit rafarma.us

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.